A "mix-and-use" approach for formulation of human clinical doses of 177Lu-DOTMP at hospital radiopharmacy for management of pain arising from skeletal metastases

Chakraborty, S.Vimalnath, K. V.Rajeswari, A.Chakravarty, R.Sarma, H. D.Radhakrishnan, E.Kamaleshwaran, K.Shinto, A. S.Dash, A.2017-12-212017-12-212017Journal of Labelled Compounds and Radiopharmaceuticals, 2017. Vol. 60 (9): pp. 410-419http://hdl.handle.net/123456789/153955001 bytestext/htmlen177Luclinical doseDOTMPmix-and-use strategypain palliationskeletal metastasesA "mix-and-use" approach for formulation of human clinical doses of 177Lu-DOTMP at hospital radiopharmacy for management of pain arising from skeletal metastasesArticle